Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06109051 · ClinicalTrials.gov registry record
EndeavorOTC™ Prospective Product Registry
A clinical trial of ADHD, sponsored by Akili Interactive Labs.
- Active
- Registry status
- 198
- Enrollment target
- 1
- Study location
NCT06109051 is a study of ADHD that is active but no longer recruiting, run by Akili Interactive Labs. The registered enrollment target is 198 participants, roughly in line with the 188-participant average among 75 other ADHD trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06109051, a study of ADHD, is active but no longer recruiting, sponsored by Akili Interactive Labs.
- ACTIVE NOT RECRUITING
- Registry status
- 198 participants
- Enrollment target
- 1
- Study location
Study Summary
The EndeavorOTC product registry aims to collect real world data from EndeavorOTC users. The objectives of this registry are to describe clinical and demographic characteristics, treatment patterns, clinical and quality of life outcomes, and healthcare utilization in EndeavorOTC users in a real-world setting.
Conditions Studied
Interventions
- DEVICE EndeavorOTC
Study Locations (1)
Massachusetts
- Akili Interactive Labs, Inc. - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2023-10-03 |
| Est. Completion | 2026-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06109051
The ClinicalTrials.gov registry entry for NCT06109051 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 188-participant average among 75 other ADHD trials with a reported enrollment target. The listed sponsor is Akili Interactive Labs, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with ADHD appearing as the primary indexed condition, and to 1 intervention - of which EndeavorOTC is the first listed.
NCT06109051 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06109051 about?
NCT06109051 is a clinical study titled "EndeavorOTC™ Prospective Product Registry". The EndeavorOTC product registry aims to collect real world data from EndeavorOTC users. The objectives of this registry are to describe clinical and demographic characteristics, treatment patterns, clinical and quality of life outcomes, and healthcare utilization in EndeavorOTC users in a real-worl...
What is the current status of trial NCT06109051?
This trial is currently active not recruiting. The enrollment target is 198 participants. The study started on 2023-10-03. Estimated completion is 2026-12-31.
What conditions does trial NCT06109051 study?
This clinical trial studies the following conditions: ADHD.
What interventions are being tested in trial NCT06109051?
The interventions under investigation include: EndeavorOTC (DEVICE).
Who is sponsoring clinical trial NCT06109051?
This trial is sponsored by Akili Interactive Labs, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06109051 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Target ADHD Executive Working Memory Replication Study
RECRUITING · NA
-
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
RECRUITING · Phase 4
-
Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI)
RECRUITING · NA
-
Evaluating Treatment of ADHD in Children with Down Syndrome
RECRUITING · Phase 4
-
Fidgeting and Attentional and Emotional Regulation in ADHD
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.